Why CEL-SCI (CVM) Shares Are Trading Higher

on MSN ago, source:

CEL-SCI Corp (NASDAQ:CVM) shares are trading higher by 18.6% to $1.98 during Wednesday’s session after the company received ...

CEL-SCI gains as FDA greenlights confirmatory study for Multikine

on MSN ago, source:

CEL-SCI (CVM) stock gains as the company receives FDA nod for a confirmatory study of its lead asset, Multikine, in head and neck cancer. Read more here.

CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer

4h ago, source:

SCI’s selection criteria defining the Multikine target population before surgery Selected patient population had 73% survival with Multikine vs. 45% without Multikine based on analysis of completed ...

CVM CEL-SCI Corporation

5d ago, source: Seeking Alpha

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States.

CEL-SCI Appoints Mario Gobbo to Its Board of Directors

15d ago, source:

VIENNA, Va., April 23, 2024 -- ( BUSINESS WIRE )--CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of ...

CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology

1mon ago, source: ADVFN

About CEL-SCI Corporation CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Multikine* (Leukocyte ...

CEL-SCI Corp CVM

19d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CEL-SCI Corporation (CVM)

15d ago, source: Yahoo Finance

VIENNA, Va., March 19, 2024--CEL-SCI’s LEAPS vaccine offers promising new paradigm to treat rheumatoid arthritis: published in Frontiers in Immunology. VIENNA, Va., March 06, 2024--CEL-SCI Corporation ...

CEL-SCI Corp CVM

27d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...